New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


COVID is less severe with Omicron than Delta, U.S. study suggests

The Omicron variant appears to result in less severe COVID-19 than seen during previous periods of high coronavirus transmission including the Delta wave, with shorter hospital stays, less need for intensive care and fewer deaths, according to a new U.S. study.


Pandemic Health Systems Reimagined in Supermind Report

The MIT Center for Collective Intelligence and MilliporeSigma brought together the thought-power of gurus in science, healthcare, public policy and other sectors to answer the question: how do we apply what we have learned from the COVID-19 pandemic for the future?  


AstraZeneca’s Hematology Cornerstone is “Completely Replacing” Previous Standards

When AstraZeneca presented positive updated results from the Phase III ASCEND study of CALQUENCE (acalabrutinib), it marked an important milestone for the company as the jewel in the crown of what management hopes will become a significant hematology portfolio. That study was significant for patients, too, because it represented a landmark 36 months of follow-up in chronic lymphocytic leukemia (CLL), which is considered an incurable disease.


Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine

Pfizer Inc. and BioNTech SE said on Jan. 25 they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen.


Rhode Island, in reversal, to settle opioid claims against U.S. drug distributors

Rhode Island on Jan. 25 reversed course and threw the state’s support behind a $21 billion nationwide settlement it originally declined to back resolving lawsuits alleging that three large drug distributors fueled the deadly U.S. opioid epidemic.


COVID-19 Brief: Omicron Mutating, Lasting Longer and Killing Faster

Two cases of a subvariant of the Omicron variant were identified in Washington state. Two cases were also identified in Houston.